Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in Cystic Fibrosis (FEMPTO)
NCT07780344Not yet recruiting
- Sponsor
- University of Nottingham
- Start
- Sep 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in cystic fibrosis (CF) comparing Placebo with linaclotide (2 arms). Primary endpoint: Small Bowel Water Content Area Under the Curve 0-6 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
linaclotide
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT07780344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07780344.